论文部分内容阅读
目的探讨康复新液联合雷贝拉唑治疗老年反流性食管炎的临床效果。方法 98例老年反流性食管炎患者,按照治疗方式的不同分为对照组和观察组,各49例。对照组单纯采用雷贝拉唑治疗,观察组采用雷贝拉唑与康复新液联合治疗,对比两组患者的临床效果。结果观察组患者的症状总有效率与内镜疗效均显著高于对照组,差异有统计学意义(P<0.05);治疗期间两组患者均无严重不良反应发生。结论康复新液与雷贝拉唑联合用药治疗老年反流性食管炎可显著提高治疗效果,且安全性较高,值得临床推广应用。
Objective To investigate the clinical effects of Kangfuxin Solution and Rabeprazole in the treatment of senile reflux esophagitis. Methods A total of 98 elderly patients with reflux esophagitis were divided into control group and observation group according to the different treatment methods, with 49 cases in each group. The rabbits in the control group were treated with rabeprazole alone. The rabeprazole group was treated with rabeprazole in combination with Kangfuxin liquid, and the clinical effect was compared between the two groups. Results The total effective rate and endoscopic efficacy of the observation group were significantly higher than those of the control group (P <0.05). No serious adverse reactions occurred in both groups during the treatment. Conclusion Kangfuxin solution combined with rabeprazole in the treatment of senile reflux esophagitis can significantly improve the therapeutic effect and is safe and worthy of clinical application.